electroCore price target lowered to $26 from $28 at Ladenburg
Ladenburg lowered the firm’s price target on electroCore (ECOR) to $26 from $28 and keeps a Buy rating on the shares. The firm is “encouraged” ...
Fintel on MSN1d
Ladenburg Thalmann Downgrades Zynex (ZYXI)
Fintel reports that on March 12, 2025, Ladenburg Thalmann downgraded their outlook for Zynex (NasdaqGS:ZYXI) from Buy to ...
Zynex downgraded to Neutral from Buy at Ladenburg
Ladenburg downgraded Zynex (ZYXI) to Neutral from Buy without a price target saying the company continues to adjust operationally amid revenue ...
Morningstar1mon
Ladenburg Aggressive Growth I
Ladenburg Aggressive Growth Fund earns an Average Process Pillar rating. The main driver of the rating is the firm's retention rate of the firm's portfolio managers, which is 100% over the ...
Morningstar1mon
Ladenburg Growth & Income I
Ladenburg Growth& Income Fund earns an Average Process Pillar rating. The leading factor in the rating is the firm's retention rate of the firm's portfolio managers, which is 100% over the ...
Fintel on MSN14d
Ladenburg Thalmann Upgrades Spire (SR)
Fintel reports that on February 26, 2025, Ladenburg Thalmann upgraded their outlook for Spire (NYSE:SR) from Sell to Buy. Analyst Price Forecast Suggests 3.79% Downside As of February 19, 2025, the ...
Wall Street Journal4d
Ladenburg Thalmann Financial Services Inc. 6.5% Notes due 2027
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
ETF Daily News4d
Ardelyx’s (ARDX) “Buy” Rating Reiterated at LADENBURG THALM/SH SH
LADENBURG THALM/SH SH reissued their buy rating on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a research report sent to investors on Friday, Marketbeat reports. The brokerage currently has ...
PharmiWeb1d
Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
ContractHeidelberg Pharma Amends Royalty Financing with HealthCare Royalty 13-March-2025 / 00:31 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, ...
ChromaDex (NASDAQ:CDXC) Price Target Raised to $8.10
ChromaDex (NASDAQ:CDXC – Free Report) had its target price upped by LADENBURG THALM/SH SH from $6.80 to $8.10 in a research ...
Investing23d
Ladenburg cuts Portland General stock rating to neutral
On Tuesday, Portland General Electric Company (NYSE:POR), currently trading at $41.64 and near its 52-week low, experienced a shift in its stock rating, as Ladenburg Thalmann analysts downgraded the ...
Nasdaq23d
Ladenburg Thalmann Upgrades Spire (SR)
Fintel reports that on February 26, 2025, Ladenburg Thalmann upgraded their outlook for Spire (NYSE:SR) from Sell to Buy. As of February 19, 2025, the average one-year price target for Spire is $ ...